Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers

NCT05965414 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: CS6253 Solution for Injection
DRUG: Placebo

Sponsor

Artery Therapeutics, Inc.

Collaborators

[object Object]